Work

Outcomes of Patients With Therapy-Related MDS After Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared With Patients With De Novo MDS: A Single-Institution Experience

Year: 2019

Type: article

Study design: Observational Study

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2019.03.003

Authors: Jason P. Cooper, Sirin Khajaviyan, Stephen D. Smith, David G. Maloney, Andrei R. Shustov, Edus H. Warren, Lorinda A. Soma, Ryan C. Lynch, Chaitra Ujjani, Brian Till, Anna B. Halpern, Ajay K. Gopal, H. Joachim Deeg, Bart L. Scott, Mazyar Shadman

Institutions: University of Washington, Fred Hutch Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: HistoGenetics, National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: Career Development in Clinical Hematology, Optimizing Nonmyeloablative Stem Cell Transplantation, Antibody directed delivery of short interfering RNA for the treatment of ovarian, CMV Entry-Specific Neutralizing Antibody in Primary Infection in Transplantation, Radioimmunotherapy of CD20+ Lymphomas & CD45+Leukemias, Hematology Training

OpenAlex ID: W2920798262

FWCI: 0.882

Cites: 33

Cited by: 6

Related to: 10